The experimental results showed that the expression of PTK2 in multiple cell lines was significant, with the expression levels of PTK2 in APL (NB4 and HL-60) significantly higher than the control group (CD34+), indicating that PTK2 plays an important role in the occurrence and development of APL (Figure 5A). The gene discussed is PTK2; the disease is acute promyelocytic leukemia.